Literature DB >> 10969770

Mutations of the bak gene in human gastric and colorectal cancers.

S Kondo1, Y Shinomura, Y Miyazaki, T Kiyohara, S Tsutsui, S Kitamura, Y Nagasawa, M Nakahara, S Kanayama, Y Matsuzawa.   

Abstract

The Bcl-2 homologue Bak is a potent inducer of apoptosis. We performed PCR-based single-strand conformational polymorphism and sequencing analysis of the entire coding region of the bak gene (exons 2-6) in 24 primary gastric cancers (6 early-stage and 18 advanced-stage cancers) and 20 primary colorectal cancers (6 early-stage and 14 advanced-stage cancers). The data herein demonstrate, for the first time, the mutation of the bak gene in gastric and colorectal cancers. Missense bak gene mutations were observed in 3 of 24 (12.5%) gastric cancers and 2 of 20 (10.0%) colorectal cancers. Sequence alterations without amino acid alteration were observed 1 of 24 (4.2%) gastric cancers and 2 of 20 (10.0%) colorectal cancers. Mutations in the bak gene were observed only in advanced-stage gastrointestinal cancers but not in early-stage cancers. Our observations suggest that mutations in this gene predispose bearers to the development of gastrointestinal malignancies in at least a subset of the cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10969770

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  23 in total

1.  The p53-Bcl-2 connection.

Authors:  M T Hemann; S W Lowe
Journal:  Cell Death Differ       Date:  2006-05-19       Impact factor: 15.828

Review 2.  The Bcl-2 apoptotic switch in cancer development and therapy.

Authors:  J M Adams; S Cory
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

3.  Diallyl trisulfide selectively causes Bax- and Bak-mediated apoptosis in human lung cancer cells.

Authors:  Dong Xiao; Yan Zeng; Eun-Ryeong Hahm; Young-Ae Kim; Suresh Ramalingam; Shivendra V Singh
Journal:  Environ Mol Mutagen       Date:  2009-04       Impact factor: 3.216

Review 4.  The essential role of evasion from cell death in cancer.

Authors:  Gemma L Kelly; Andreas Strasser
Journal:  Adv Cancer Res       Date:  2011       Impact factor: 6.242

5.  TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

Authors:  Yibin Deng; Yahong Lin; Xiangwei Wu
Journal:  Genes Dev       Date:  2002-01-01       Impact factor: 11.361

6.  Analysis of p53 and Bak gene mutations in lymphoproliferative disorders developing in rheumatoid arthritis.

Authors:  Jing-Xian Xu; Yoshihiko Hoshida; Tadashi Hongyo; Toru Sasaki; Hajime Miyazato; Yasuhiko Tomita; Katsuyuki Aozasa
Journal:  J Cancer Res Clin Oncol       Date:  2006-09-20       Impact factor: 4.553

7.  Defective mucosal T cell death is sustainably reverted by infliximab in a caspase dependent pathway in Crohn's disease.

Authors:  A Di Sabatino; R Ciccocioppo; B Cinque; D Millimaggi; R Morera; L Ricevuti; M G Cifone; G R Corazza
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

8.  Pro-apoptotic PUMA and anti-apoptotic phospho-BAD are highly expressed in colorectal carcinomas.

Authors:  Mi R Kim; Eun G Jeong; Boa Chae; Jong W Lee; Young H Soung; Suk W Nam; Jung Y Lee; Nam J Yoo; Sug H Lee
Journal:  Dig Dis Sci       Date:  2007-03-28       Impact factor: 3.199

9.  BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with ataxia telangiectasia.

Authors:  Anna Isaian; Natalia V Bogdanova; Masoud Houshmand; Masoud Movahadi; Asghar Aghamohammadi; Asghar Agamohammadi; Nima Rezaei; Lida Atarod; Mahnaz Sadeghi-Shabestari; Seyed Hasan Tonekaboni; Zahra Chavoshzadeh; Seyed Mohammad Seyed Hassani; Reza Mirfakhrai; Taher Cheraghi; Najmoddin Kalantari; Mitra Ataei; Thilo Dork-Bousset; Mohammad Hossein Sanati
Journal:  J Clin Immunol       Date:  2009-11-07       Impact factor: 8.317

10.  Expressional and mutational analysis of pro-apoptotic Bcl-2 member PUMA in hepatocellular carcinomas.

Authors:  Chang H Ahn; Eun G Jeong; Sung S Kim; Jong W Lee; Sung H Lee; Sung H Kim; Min S Kim; Nam J Yoo; Sug Hyung Lee
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.